Robert Hagemann
Robert Hagemann's purchase track record
Robert Hagemann has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/8/2026 | GPK | $154K | +15.0% | pending | — |
| 8/28/2023 | ZBH | $233K | -2.9% | +8.4% | +14.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Ryder System faces mixed analyst ratings and price target changes. Ryder System is experiencing a split in analyst sentiment this week. JP Morgan upgraded the stock to Overweight with a $298 price target, while Baird downgraded it to Neutral and Susquehanna lowered its target to $280. These moves reflect differing views on the company's outlook, with the average analyst target sitting at $291.22.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Zimmer Biomet Extends Exclusive Distribution Deal with Think Surgical. Zimmer Biomet has extended its exclusive distribution agreement with Think Surgical to supply the wireless TMINI miniature robotic system. The deal expands the company's reach in surgical robotics and aligns with its strategy of partnering with innovative technology providers. It follows strong Q2 results that benchmarked well against peers in the surgical equipment sector, reinforcing Zimmer Biomet’s competitive position within the S&P 500.
Transaction History
| GPK | ▲ Buy | Open Market | 14,000 | $154K | 5/8/2026 | View on chart |
| R | ▲ Buy | Grant | 720 | $0 | 5/1/2026 | View on chart |
| R | ▲ Buy | Grant | 677 | $0 | 5/1/2026 | View on chart |
| R | ▲ Buy | Grant | 1,243 | $0 | 5/2/2025 | View on chart |
| R | ▲ Buy | Grant | 704 | $0 | 12/20/2024 | View on chart |
| R | ▲ Buy | Grant | 1,443 | $0 | 5/3/2024 | View on chart |
| R | ▲ Buy | Grant | 632 | $0 | 12/15/2023 | View on chart |
| ZBH | ▲ Buy | Open Market | 2,000 | $233K | 8/28/2023 | View on chart |
| R | ▲ Buy | Grant | 2,112 | $0 | 5/5/2023 | View on chart |
| R | ▲ Buy | Grant | 608 | $0 | 12/16/2022 | View on chart |
| R | ▲ Buy | Grant | 2,220 | $0 | 5/6/2022 | View on chart |
| R | ▲ Buy | Grant | 511 | $0 | 12/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
UBS Lowers Graphic Packaging Price Target to $9.50
UBS has lowered its price target for Graphic Packaging Holding to $9.50 while maintaining a Neutral rating. This move brings the firm's outlook closer to the stock's current trading levels, which are hovering near a key support area. The update reflects a cautious stance from the bank regarding the company's near-term prospects.
UBS Lowers Graphic Packaging Price Target to $9.50. UBS has lowered its price target for Graphic Packaging Holding to $9.50 while maintaining a Neutral rating. This move brings the firm's outlook closer to the stock's current trading levels, which are hovering near a key support area. The update reflects a cautious stance from the bank regarding the company's near-term prospects.